Tara Lech, PharmD
@anticoagpharmd.bsky.social
Systems Director, Anticoag Services, Beth Israel Lahey Health #AnticoagStewardship is my jam
Co-Chair Vasculearn Medical Advisory Board
AC Forum ACE Ambassador
Mom of 3 🧘🏻♀️✌🏼 #HemeSky #CardioSky #SkyRx #CardioOncology #PharmRx
Co-Chair Vasculearn Medical Advisory Board
AC Forum ACE Ambassador
Mom of 3 🧘🏻♀️✌🏼 #HemeSky #CardioSky #SkyRx #CardioOncology #PharmRx
Excited to share this article highlighting the important role of Antithrombosis Stewardship to improve Safe Transitions of Care in pts with VTE.
#Stewardship #Anticoagulation #AntithromboticStewardship #TransitionsofCare
@jthjournal.bsky.social @isth.org
www.sciencedirect.com:5037/science/arti...
#Stewardship #Anticoagulation #AntithromboticStewardship #TransitionsofCare
@jthjournal.bsky.social @isth.org
www.sciencedirect.com:5037/science/arti...
www.sciencedirect.com
December 3, 2025 at 11:38 PM
Excited to share this article highlighting the important role of Antithrombosis Stewardship to improve Safe Transitions of Care in pts with VTE.
#Stewardship #Anticoagulation #AntithromboticStewardship #TransitionsofCare
@jthjournal.bsky.social @isth.org
www.sciencedirect.com:5037/science/arti...
#Stewardship #Anticoagulation #AntithromboticStewardship #TransitionsofCare
@jthjournal.bsky.social @isth.org
www.sciencedirect.com:5037/science/arti...
Reposted by Tara Lech, PharmD
📢📢NEW research from @jthjournal.bsky.social!
Two new papers were released on stroke risk and prediction in #atrialfibrillation. Whether you’re a clinician or researcher, you won’t want to miss these insights. Visit jthjournal.org to explore this new research. #stroke #afib #af
Two new papers were released on stroke risk and prediction in #atrialfibrillation. Whether you’re a clinician or researcher, you won’t want to miss these insights. Visit jthjournal.org to explore this new research. #stroke #afib #af
August 6, 2025 at 2:38 PM
📢📢NEW research from @jthjournal.bsky.social!
Two new papers were released on stroke risk and prediction in #atrialfibrillation. Whether you’re a clinician or researcher, you won’t want to miss these insights. Visit jthjournal.org to explore this new research. #stroke #afib #af
Two new papers were released on stroke risk and prediction in #atrialfibrillation. Whether you’re a clinician or researcher, you won’t want to miss these insights. Visit jthjournal.org to explore this new research. #stroke #afib #af
Who would have thought VTE management could be so much fun!
Thank you @thecurbsiders.bsky.social 🫶🏼
#PharmSky #MedSky #CardioSky #SkyRx #HemeSky
@anticoagforum.bsky.social
Thank you @thecurbsiders.bsky.social 🫶🏼
#PharmSky #MedSky #CardioSky #SkyRx #HemeSky
@anticoagforum.bsky.social
🎧 New #Curbsiders episode!
💊 #490: Anticoagulation for VTE w/ Dr. Tara Lech, PharmD @anticoagpharmd.bsky.social
✅ Choosing the right DOAC
🤰 Special pops: pregnancy, low BMI
✈️ Air travel prophylaxis
🚨 Treatment failure & reversal agents
🔗 Listen now: www.thecurbsiders.com
💊 #490: Anticoagulation for VTE w/ Dr. Tara Lech, PharmD @anticoagpharmd.bsky.social
✅ Choosing the right DOAC
🤰 Special pops: pregnancy, low BMI
✈️ Air travel prophylaxis
🚨 Treatment failure & reversal agents
🔗 Listen now: www.thecurbsiders.com
July 7, 2025 at 5:46 PM
Who would have thought VTE management could be so much fun!
Thank you @thecurbsiders.bsky.social 🫶🏼
#PharmSky #MedSky #CardioSky #SkyRx #HemeSky
@anticoagforum.bsky.social
Thank you @thecurbsiders.bsky.social 🫶🏼
#PharmSky #MedSky #CardioSky #SkyRx #HemeSky
@anticoagforum.bsky.social
💥If you want to see practice changing highlights from #ISTH2025, you can check out the VLN Newsletter vln.thrombosis.org/c/clinical-r...
or log in to the VLN ISTH 2025 Community Page lnkd.in/eyrrr4qZ to see ALL the posts and interact with the community.
I look forward to seeing you there!
or log in to the VLN ISTH 2025 Community Page lnkd.in/eyrrr4qZ to see ALL the posts and interact with the community.
I look forward to seeing you there!
ISTH 2025 Congress Highlights: What You Might Have Missed | Vasculearn Network
Key Insights from our Board members, @Alfonso J Tafur and @Tara K. Lech
Log in to https://vln.thrombosis.org and check out the ISTH 2025 Community Page for more details & even more presentations not...
vln.thrombosis.org
June 27, 2025 at 9:28 PM
💥If you want to see practice changing highlights from #ISTH2025, you can check out the VLN Newsletter vln.thrombosis.org/c/clinical-r...
or log in to the VLN ISTH 2025 Community Page lnkd.in/eyrrr4qZ to see ALL the posts and interact with the community.
I look forward to seeing you there!
or log in to the VLN ISTH 2025 Community Page lnkd.in/eyrrr4qZ to see ALL the posts and interact with the community.
I look forward to seeing you there!
Reposted by Tara Lech, PharmD
Vasculearn Network is hosting a Women's Health Support Group May 12th @ 7PM EST
This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis
👉Register lnkd.in/esHHKW62
This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis
👉Register lnkd.in/esHHKW62
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
May 10, 2025 at 9:48 PM
Vasculearn Network is hosting a Women's Health Support Group May 12th @ 7PM EST
This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis
👉Register lnkd.in/esHHKW62
This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis
👉Register lnkd.in/esHHKW62
Did you know that NATF has rebranded? Check out the brand new Vasculearn Network: www.google.com/url?q=https:...
Their dynamic site is full of great resources for patients & providers.
I personally love their patient support groups and reading What’s Hot in Clots by @bbikdeli.bsky.social!
Their dynamic site is full of great resources for patients & providers.
I personally love their patient support groups and reading What’s Hot in Clots by @bbikdeli.bsky.social!
Redirecting
www.google.com
April 8, 2025 at 8:00 PM
Did you know that NATF has rebranded? Check out the brand new Vasculearn Network: www.google.com/url?q=https:...
Their dynamic site is full of great resources for patients & providers.
I personally love their patient support groups and reading What’s Hot in Clots by @bbikdeli.bsky.social!
Their dynamic site is full of great resources for patients & providers.
I personally love their patient support groups and reading What’s Hot in Clots by @bbikdeli.bsky.social!
Outpatient management of CAT? Insightful review from @marccarriermd.bsky.social @drdebthrombo.bsky.social & colleagues
publications.ersnet.org/content/erj/...
publications.ersnet.org/content/erj/...
Outpatient management of cancer-associated pulmonary embolism: a systematic review and meta-analysis
Graphical abstracterj;65/4/2401596/GA1F1GA1Overview of the study. (s)PESI: (simplified) Pulmonary Embolism Severity Index; VTE: venous thromboembolism.
publications.ersnet.org
April 8, 2025 at 2:45 AM
Outpatient management of CAT? Insightful review from @marccarriermd.bsky.social @drdebthrombo.bsky.social & colleagues
publications.ersnet.org/content/erj/...
publications.ersnet.org/content/erj/...
Reposted by Tara Lech, PharmD
Excited to share an important new document from ACForum and FWGBD addressing the care of folks with the potential to menstruate (or enter menopause!) or become pregnant. Check it out! acforum.org/web/resource...
acforum.org
March 26, 2025 at 3:25 PM
Excited to share an important new document from ACForum and FWGBD addressing the care of folks with the potential to menstruate (or enter menopause!) or become pregnant. Check it out! acforum.org/web/resource...
📢 Calling all Anticoagulation Specialists! Come join our comprehenisve management program. We care for patients on warfarin & DOACs with an emphasis on #Stewardship #Quality and #Equity
Please reach out with any questions
#jobs #hiring #pharmsky #skyrx #anticoagualtion
jobs.bilh.org/job/cambridg...
Please reach out with any questions
#jobs #hiring #pharmsky #skyrx #anticoagualtion
jobs.bilh.org/job/cambridg...
Clinical Pharmacist Specialist Anticoagulation Hybrid / Remote (Burlington, MA.) at Beth Israel Lahey Health
Learn more about applying for Clinical Pharmacist Specialist Anticoagulation Hybrid / Remote (Burlington, MA.) at Beth Israel Lahey Health.
jobs.bilh.org
March 11, 2025 at 1:13 AM
📢 Calling all Anticoagulation Specialists! Come join our comprehenisve management program. We care for patients on warfarin & DOACs with an emphasis on #Stewardship #Quality and #Equity
Please reach out with any questions
#jobs #hiring #pharmsky #skyrx #anticoagualtion
jobs.bilh.org/job/cambridg...
Please reach out with any questions
#jobs #hiring #pharmsky #skyrx #anticoagualtion
jobs.bilh.org/job/cambridg...
Reposted by Tara Lech, PharmD
The @medscape.com Heart of Cardiology 2025 conference started yesterday with several stellar presentations! Here are a few key take away points that I’ve been thinking about… www.heartofcardio.com/agenda
Agenda
Our comprehensive agenda will cover Cardiometabolic Health, Cardiovascular Prevention, Atherosclerosis, Thrombosis, Cardiovascular Dysfunction, Arrhythmias, Valvular Heart Disease and more.
www.heartofcardio.com
January 25, 2025 at 1:50 PM
The @medscape.com Heart of Cardiology 2025 conference started yesterday with several stellar presentations! Here are a few key take away points that I’ve been thinking about… www.heartofcardio.com/agenda
Ok, here is the big lesson learned:
💡 When setting up the transfer device the Balfaxar vial MUST be on a solid flat surface so you can push down with force
- We observed team members just connecting the 2 vials, and this led to a loss in the seal & increased transfer times
#pharmRx #SkyRx #PharmSky
💡 When setting up the transfer device the Balfaxar vial MUST be on a solid flat surface so you can push down with force
- We observed team members just connecting the 2 vials, and this led to a loss in the seal & increased transfer times
#pharmRx #SkyRx #PharmSky
January 14, 2025 at 12:53 PM
💡In this study, < 25% of pts with a major bleed had documented discussions about LAAO & > 25% permanently 🚫 anticoag. Education & shared decision making is vital. These pt are still at risk for embolic events pubmed.ncbi.nlm.nih.gov/39644619/?ut... @gbarnesmd.bsky.social
Prevalence of discussions around left atrial appendage occlusion as a treatment option in patients on oral anticoagulation experiencing a major bleeding event - PubMed
In patients experiencing a major bleed, less than a quarter had documented discussions about LAAO and over a quarter permanently stopped anticoagulation.
pubmed.ncbi.nlm.nih.gov
January 9, 2025 at 11:45 PM
💡In this study, < 25% of pts with a major bleed had documented discussions about LAAO & > 25% permanently 🚫 anticoag. Education & shared decision making is vital. These pt are still at risk for embolic events pubmed.ncbi.nlm.nih.gov/39644619/?ut... @gbarnesmd.bsky.social
I am a big fan of practicle papers! It is great to see how providers are handling these interactions and what the impact on patient outcomes
#PharmRx #Skypharm #Hemesky #MedSky
pubmed.ncbi.nlm.nih.gov/39643974/
#PharmRx #Skypharm #Hemesky #MedSky
pubmed.ncbi.nlm.nih.gov/39643974/
Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding...
Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding...
pubmed.ncbi.nlm.nih.gov
January 9, 2025 at 11:34 PM
I am a big fan of practicle papers! It is great to see how providers are handling these interactions and what the impact on patient outcomes
#PharmRx #Skypharm #Hemesky #MedSky
pubmed.ncbi.nlm.nih.gov/39643974/
#PharmRx #Skypharm #Hemesky #MedSky
pubmed.ncbi.nlm.nih.gov/39643974/
Is anyone routinely checking DOAC levels and changing therapy as a result?
Curious to see what others are doing in practice #SkyRx #PharmSky #MedSky
pubmed.ncbi.nlm.nih.gov/38884944/
Curious to see what others are doing in practice #SkyRx #PharmSky #MedSky
pubmed.ncbi.nlm.nih.gov/38884944/
A Pilot Study Describing DOAC Level Results and Association With Clinical Outcomes - PubMed
<span><b>Purpose:</b> Describe direct oral anticoagulant (DOAC) level ordering and interpretation practices in association with clinical outcomes at a vascular medicine clinic. <b>Methods:</b> This st...
pubmed.ncbi.nlm.nih.gov
December 23, 2024 at 3:20 PM
Is anyone routinely checking DOAC levels and changing therapy as a result?
Curious to see what others are doing in practice #SkyRx #PharmSky #MedSky
pubmed.ncbi.nlm.nih.gov/38884944/
Curious to see what others are doing in practice #SkyRx #PharmSky #MedSky
pubmed.ncbi.nlm.nih.gov/38884944/
👀 🚨 FDA denies full approval of Andexanet
Can’t say I am surprised. It will be interesting to see what happens next
#SkyRx #PharmSky #CardioSky #HemeSky
firstwordpharma.com/story/5921956
Can’t say I am surprised. It will be interesting to see what happens next
#SkyRx #PharmSky #CardioSky #HemeSky
firstwordpharma.com/story/5921956
FirstWord
firstwordpharma.com
December 18, 2024 at 2:15 AM
👀 🚨 FDA denies full approval of Andexanet
Can’t say I am surprised. It will be interesting to see what happens next
#SkyRx #PharmSky #CardioSky #HemeSky
firstwordpharma.com/story/5921956
Can’t say I am surprised. It will be interesting to see what happens next
#SkyRx #PharmSky #CardioSky #HemeSky
firstwordpharma.com/story/5921956
💡Great for trainees!
#AnticoagStewardship #CardioSky
#MedSky #PharmSky #SkyRx @bbikdeli.bsky.social
pubmed.ncbi.nlm.nih.gov/39557062/
#AnticoagStewardship #CardioSky
#MedSky #PharmSky #SkyRx @bbikdeli.bsky.social
pubmed.ncbi.nlm.nih.gov/39557062/
Direct Oral Anticoagulants: Quick Primer on When to Use and When to Avoid - PubMed
Direct oral anticoagulants (DOACs) have transformed the landscape of antithrombotic therapy in the past two decades. However, there is uncertainty about when they should or should not be used for trea...
pubmed.ncbi.nlm.nih.gov
November 27, 2024 at 2:12 AM
🌟 Good read on how to apply the CHADSVaSc score in clinical practice @gbarnesmd.bsky.social & #GregoryLip #CardioSky #PharmSky #SkyRx #Afib #AnticoagStewardship
pubmed.ncbi.nlm.nih.gov/39365222/
pubmed.ncbi.nlm.nih.gov/39365222/
Applying Clinical Risk Scores in Real-World Practice: The CHA2DS2-VASc Score in Atrial Fibrillation - PubMed
Applying Clinical Risk Scores in Real-World Practice: The CHA2DS2-VASc Score in Atrial Fibrillation
pubmed.ncbi.nlm.nih.gov
November 27, 2024 at 2:03 AM
🌟 Good read on how to apply the CHADSVaSc score in clinical practice @gbarnesmd.bsky.social & #GregoryLip #CardioSky #PharmSky #SkyRx #Afib #AnticoagStewardship
pubmed.ncbi.nlm.nih.gov/39365222/
pubmed.ncbi.nlm.nih.gov/39365222/
Reposted by Tara Lech, PharmD
We *tried* to do a meta-analysis on menstrual bleeding in FXI inhibitor studies - not only is it not an outcome, but hardly any participants were capable of menstruation. We call for action to improve capture of HMB in anticoagulant trials in our latest @jthjournal.bsky.social pub. t.co/c26Y0umzOi
https://authors.elsevier.com/a/1k6ci5TuFxIuhI
t.co
November 26, 2024 at 8:59 PM
We *tried* to do a meta-analysis on menstrual bleeding in FXI inhibitor studies - not only is it not an outcome, but hardly any participants were capable of menstruation. We call for action to improve capture of HMB in anticoagulant trials in our latest @jthjournal.bsky.social pub. t.co/c26Y0umzOi
🚨 Great teaching article
💡Review of cancer therapies that ⬆️ risk of arrhythmias (Did you know Ibrutinib ⬆️ AF risk by 15 fold 🤯)
💡Rate control typically preferred
💡AC can be challenging in frail, pancytopenic, ⬆️🩸risk pts
💡👀 for DDIs
🌟Tailor therapy
#CardioSky #SkyRx
pubmed.ncbi.nlm.nih.gov/39551561/
💡Review of cancer therapies that ⬆️ risk of arrhythmias (Did you know Ibrutinib ⬆️ AF risk by 15 fold 🤯)
💡Rate control typically preferred
💡AC can be challenging in frail, pancytopenic, ⬆️🩸risk pts
💡👀 for DDIs
🌟Tailor therapy
#CardioSky #SkyRx
pubmed.ncbi.nlm.nih.gov/39551561/
Arrhythmia Challenges in Cardio-Oncology: High-Risk Therapies, Management, and Anticoagulation - PubMed
Cardiovascular disease and cancer are the leading cause of mortality in the United States. In 2021, there were 695,547 and 605,213 deaths due to heart disease and cancer, respectively. With novel onco...
pubmed.ncbi.nlm.nih.gov
November 26, 2024 at 2:02 PM
🚨 Great teaching article
💡Review of cancer therapies that ⬆️ risk of arrhythmias (Did you know Ibrutinib ⬆️ AF risk by 15 fold 🤯)
💡Rate control typically preferred
💡AC can be challenging in frail, pancytopenic, ⬆️🩸risk pts
💡👀 for DDIs
🌟Tailor therapy
#CardioSky #SkyRx
pubmed.ncbi.nlm.nih.gov/39551561/
💡Review of cancer therapies that ⬆️ risk of arrhythmias (Did you know Ibrutinib ⬆️ AF risk by 15 fold 🤯)
💡Rate control typically preferred
💡AC can be challenging in frail, pancytopenic, ⬆️🩸risk pts
💡👀 for DDIs
🌟Tailor therapy
#CardioSky #SkyRx
pubmed.ncbi.nlm.nih.gov/39551561/
Are your patients looking for a safe space to ask questions & receive accurate information about their blood clots?
The Vasculearn Network, offers free monthly virtual support groups for patients with blood clots. Along with focused sessions for:
-Long PE/CTEPH
-Cancer
-Women’s Health
#HemeSky
The Vasculearn Network, offers free monthly virtual support groups for patients with blood clots. Along with focused sessions for:
-Long PE/CTEPH
-Cancer
-Women’s Health
#HemeSky
November 20, 2024 at 11:56 PM
Are your patients looking for a safe space to ask questions & receive accurate information about their blood clots?
The Vasculearn Network, offers free monthly virtual support groups for patients with blood clots. Along with focused sessions for:
-Long PE/CTEPH
-Cancer
-Women’s Health
#HemeSky
The Vasculearn Network, offers free monthly virtual support groups for patients with blood clots. Along with focused sessions for:
-Long PE/CTEPH
-Cancer
-Women’s Health
#HemeSky
Reposted by Tara Lech, PharmD
What do we need to focus on de-prescribing on CVD?
Dr. Schwartz gives a good state of the field. Polypharmacy 💊💊 + age = higher complications & 💊🚫 interactions. Huge need to systematically withdrawal low-value “inappropriate” medications #AHA24 #CardioSky
Dr. Schwartz gives a good state of the field. Polypharmacy 💊💊 + age = higher complications & 💊🚫 interactions. Huge need to systematically withdrawal low-value “inappropriate” medications #AHA24 #CardioSky
November 17, 2024 at 5:02 PM
What do we need to focus on de-prescribing on CVD?
Dr. Schwartz gives a good state of the field. Polypharmacy 💊💊 + age = higher complications & 💊🚫 interactions. Huge need to systematically withdrawal low-value “inappropriate” medications #AHA24 #CardioSky
Dr. Schwartz gives a good state of the field. Polypharmacy 💊💊 + age = higher complications & 💊🚫 interactions. Huge need to systematically withdrawal low-value “inappropriate” medications #AHA24 #CardioSky
Reposted by Tara Lech, PharmD
The CDC and WHO report a 20% increase in measles cases last year, driven by decreases in vaccination.
This equated to 107,500 DEATHS, mostly in young children.
This, in a PREVENTABLE disease.
Can only imagine what that number will be if we get rid of all mandates.
This equated to 107,500 DEATHS, mostly in young children.
This, in a PREVENTABLE disease.
Can only imagine what that number will be if we get rid of all mandates.
November 15, 2024 at 6:47 PM
The CDC and WHO report a 20% increase in measles cases last year, driven by decreases in vaccination.
This equated to 107,500 DEATHS, mostly in young children.
This, in a PREVENTABLE disease.
Can only imagine what that number will be if we get rid of all mandates.
This equated to 107,500 DEATHS, mostly in young children.
This, in a PREVENTABLE disease.
Can only imagine what that number will be if we get rid of all mandates.